Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
31.25 HKD | -4.58% | -5.84% | -11.03% |
25/04 | Hangzhou Tigermed Consulting’s Profit Down 59% in Q1 | MT |
25/04 | Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024 | CI |
Evolution of the average Target Price on Hangzhou Tigermed Consulting Co., Ltd
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Hangzhou Tigermed Consulting Co., Ltd
Nomura | |
UBS |
EPS Revisions
- Stock Market
- Equities
- 300347 Stock
- 3347 Stock
- Consensus Hangzhou Tigermed Consulting Co., Ltd